6th Sep 2023

UKCA marking achieved for new Genedrive® CYP2C19 test

genedrive Point of Care test that helps manage treatment in stroke patients is now readying for...

16th Jun 2023

Multi-partner grant awarded for the validation of Genedrive® CYP2C19 ID Kit in time critical NHS settings

genedrive plc (the “Company”), the point of care molecular diagnostics company, today annou...

31st Mar 2023

Interim results to 31 December 2022

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces unaudited i...